Neptune, NJ, United States of America

Renee M Chabin

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renee M Chabin. Retrieved from https://idiyas.com/inventor/renee-m-chabin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Renee M Chabin

Introduction

Renee M Chabin is a notable inventor based in Neptune, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of assays that enhance our understanding of metabolic pathways. Her work is characterized by a focus on enzyme inhibitors and their detection.

Latest Patents

Renee M Chabin holds a patent for a "Metabolic pathway assay." This innovative in vitro screening assay identifies enzyme inhibitors and allows for the simultaneous assay of many enzymes. The assay optimizes concentrations of enzymes, substrates, co-factors, and other components to ensure that inhibitors of any one enzyme in the pathway are equally likely to be detected. The flux of substrate through each enzyme is maintained at nearly the same rate during the assay, making each enzyme-catalyzed step equally rate-limiting. Optimal assay conditions are predicted through computer modeling, and pathway conditions are fine-tuned by varying concentrations of enzymes, starting substrates, co-substrates, and co-factors. A positive response is detected as a change in the amount of product generated at the end of the enzyme cascade compared to a standard, allowing for the deconvolution of samples producing positive results.

Career Highlights

Renee M Chabin is currently associated with Merck & Co., Inc., where she continues to apply her expertise in biochemistry and assay development. Her innovative approach has contributed to advancements in drug discovery and enzyme research.

Collaborations

Throughout her career, Renee has collaborated with esteemed colleagues, including David W Kuo and John F O'Connell. These collaborations have further enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Renee M Chabin's contributions to the field of biochemistry through her innovative patent and collaborations highlight her role as a leading inventor. Her work continues to influence the understanding of metabolic pathways and enzyme interactions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…